Steven M Smith, PharmD, MPH, FCCP, FAHA
Associate Professor & Chair, Pharmaceutical Outcomes & Policy; Co-Director, Center For Integrative Cardiovascular And Metabolic Disease
On This Page
About Steven M Smith
Steven Smith is an Associate Professor and Chair of the Department of Pharmaceutical Outcomes and Policy, with a courtesy appointment in the Division of Cardiovascular Medicine (College of Medicine). He also serves as Co-Director for the UF Center for Integrative Cardiovascular and Metabolic Diseases.
He received his PharmD degree from the University of Florida College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine during which time he participated in the Advanced Postgraduate Program in Clinical Investigation (APPCI) and concurrently completed the requirements for a Master of Public Health. Dr. Smith joined the faculty at the University of Colorado in 2011. He returned to the University of Florida in 2014.
Dr. Smith’s research is in the area of cardiovascular pharmacotherapy, in particular hypertension and cardiometabolic disease, and is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the U.S. Department of Defense. He is an elected Fellow in the American Heart Association and the American College of Clinical Pharmacy, as well as a member of the American College of Cardiology, American Association of Colleges of Pharmacy and the International Society for Pharmacoepidemiology. He also has served in several leadership roles nationally, including on the Examination Committee for the American Society of Hypertension Specialists’ Program (ASHSP) Certified Hypertension Clinician program, in several initiatives through the American Heart Association Hypertension Council, on the Board of Directors for the Consortium for Southeastern Hypertension Control (2019-2023 term), and as a founding member of the CDC’s National Hypertension Control Roundtable.
Dr. Smith co-coordinates a graduate course on Measurement in Pharmaceutical Outcomes Research.
From 2014 to 2023, Dr. Smith also co-directed the UF Family Medicine Pharmacy Fellowship.
Accomplishments
-
Fellow
American Heart Association
-
Teaching and Service Excellence Award
University of Florida College of Pharmacy
-
Excellence Award for Assistant Professors
University of Florida
-
Fellow
American College of Clinical Pharmacy
-
Delta Omega Inductee
University of Florida College of Public Health & Health Professions
-
Teaching and Service Excellence Award
University of Florida College of Pharmacy
-
New Investigator Award
American College of Clinical Pharmacy
-
Anniversary Fellow in Pharmacy
National Academy of Medicine
Teaching Profile
Courses Taught
-
PHA5007 – Pharm and Pop Health
College of Pharmacy
-
PHA5788 – Pharmacotherapy 6
College of Pharmacy
-
PHA5788C – Patient Care 6
College of Pharmacy
-
PHA7979 – Advanced Research
College of Pharmacy
-
PHA6265 – Introduction to Pharmaceutical Outcomes and Policy I
College of Pharmacy
-
PHA6910 – Supervised Research
College of Pharmacy
-
PHA7980 – Research for Doctoral Dissertation
College of Pharmacy
-
PHA6946 – Practicum in the Pharmaceutical Sciences
College of Pharmacy
-
PHA5223 – P-Epidem Drug Safety
College of Pharmacy
-
PHA6717 – Measurement in Pharmaceutical Outcomes and Policy Research
College of Pharmacy
Board Certifications
-
Board-Certified Pharmacotherapy SpecialistBoard of Pharmaceutical Specialties
-
Certified Hypertension ClinicianAmerican Hypertension Specialist Certification Program
Research Profile
Dr. Smith’s research lab focuses on understanding and improving use of cardiovascular-related drug therapy in the real world to reduce risk of major adverse outcomes at the population level. Hypertension and its treatment are the major area of focus, and Dr. Smith has particular expertise in the area of difficult-to-control, or ‘resistant’ hypertension.
His lab employs a variety of observational methodologic approaches and data sources, including EHR, administrative claims, and prospective cohort and randomized clinical trial data. Strong collaborations within the College of Pharmacy include with faculty and trainees in the Cardiovascular group of the Department of Pharmaceutical Outcomes and Policy and the Center for Drug Evaluation and Safety as well as with the Department of Pharmacotherapy and Translational Research. Outside of the College, Dr. Smith’s group works closely with the Division of Cardiovascular Medicine and the Center for Integrative Cardiovascular and Metabolic Diseases, where Dr. Smith serves as Co-Director.
Current funding for the lab is through the National Heart, Lung and Blood Institute (studying minocycline as a treatment for resistant hypertension; what drives antihypertensive prescribing and how to optimize early therapy; antihypertensive prescribing cascades; and, studying apparent treatment-resistant hypertension in the All-of-Us program), PCORI (hypertension surveillance through the BP Control Lab), and the U.S. Department of Defense (the WARRIOR trial).
Areas of Interest
- Cardiometabolic Disease
- Cardiovascular Epidemiology
- Hypertension
- Pharmacoepidemiology
- Resistant Hypertension
Publications
Academic Articles
Grants
-
Analyzing effectiveness of ongoing natural experiments in telehealth
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NHLBI
-
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis
Active
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NHLBI
-
Hypertension Prediction and Identification in All of Us
Active
- Role:
- Co-Investigator
- Funding:
- NATL INST OF HLTH NHLBI
-
Real-World Trajectories of Xanthine Oxidase Inhibitor Use and Downstream Cardiovascular Outcomes
- Role:
- Other
- Funding:
- AMER HEART ASSOCIATION
-
High-throughput screening for antihypertensive prescribing cascades
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NHLBI
-
Using PCORnet to Compare Blood Pressure Control Strategies
- Role:
- Co-Investigator
- Funding:
- UNIV OF CALIFORNIA SAN FRANCISCO via PATIENT-CENTERED OUTCOMES RES INST
-
Advancing Personalized Hypertension Care through Big Data Science
- Role:
- Principal Investigator
- Funding:
- NATL INST OF HLTH NHLBI
-
Women’s Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
- Role:
- Co-Investigator
- Funding:
- US ARMY MED RES ACQUISITION
-
Clinical and Translational Science Institute (CTSI)
- Role:
- Project Manager
- Funding:
- UF DIV OF SPONSORED RES MATCHING FUNDS
-
Institute of Medicine Anniversary Fellow in Pharmacy
- Role:
- Principal Investigator
- Funding:
- NATL ACAD OF SCIENCES
Education
-
Graduate Certificate in Biomedical Informatics
University of Florida
-
M.P.H.
University of Florida
-
Postdoctoral Fellow
University of Florida
-
Pharmacy Practice Residency
NF/SG Veterans Affairs Health System, Gainesville, FL
-
Pharm.D.
University of Florida
Contact Details
- Business:
- (352) 273-5134
- Business:
- ssmithm@ufl.edu
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
1889 MUSEUM RD STE 6300
DSIT BLDG
GAINESVILLE FL 32611